Who Paid My Doc
Nicholas Camp
Pain Medicine Bentonville, AR Medical Doctor
NPI 1861753709 CMS profile 3053340
2900 Medical Center Pkwy Ste 110, Bentonville, AR 72712
General payments
$3,642
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Nicholas Camp of Bentonville, AR is reported in the CMS Open Payments database as having received $3,642 across 89 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 59th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $295 | 14 | |
| 2024 | General | $221 | 10 | |
| 2023 | General | $304 | 10 | |
| 2022 | General | $1,188 | 18 | |
| 2021 | General | $1,211 | 15 | |
| 2020 | General | $290 | 18 | |
| 2019 | General | $133 | 4 |
Beside peers
- Nicholas Camp
- Pain Medicine median
- Middle half of Pain Medicine
- National median
In program year 2025, general payments to Nicholas Camp were reported at $295. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.
Show as a table
| Year | Nicholas Camp | Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $133 | $498 | $126–$1,682 | $163 |
| 2020 | $290 | $284 | $80–$910 | $114 |
| 2021 | $1,211 | $399 | $112–$1,219 | $132 |
| 2022 | $1,188 | $455 | $137–$1,484 | $149 |
| 2023 | $304 | $484 | $128–$1,495 | $160 |
| 2024 | $221 | $498 | $131–$1,540 | $164 |
| 2025 | $295 | $458 | $124–$1,401 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 9 drugsPart D claims
230
Drug cost
$1,888
Branded share of claims
39.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 43 | $488 | |
| Pregabalin | Generic | 33 | $423 | |
| Gabapentin | Generic | 51 | $311 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 21 | $243 | |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | Brand | 12 | $177 | |
| Tizanidine Hcl | Generic | 14 | $112 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 14 | $85 | |
| Meloxicam | Generic | 20 | $35 | |
| Alprazolam | Generic | 22 | $15 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.
Records
89 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pain Medicine in Arkansas
Related records
Pain Medicine in Arkansas
Practitioners in the same specialty and state, ranked by reported value.
All Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Arkansas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.